Anzeige
Mehr »
Login
Samstag, 26.09.2020 Börsentäglich über 12.000 News von 645 internationalen Medien
Zwei Bilder sagen mehr als 2.000 Worte! Auf den Spuren einer "Ruckzuck-Milliardenbewertung"!?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PharmaTimes

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrMonte Rosa Therapeutics raises $96m to develop protein-degrading molecules
FrUK consumers seeking advice from pharmacists during pandemic, research finds
FrNovavax begins phase III coronavirus vaccine trial in the UK
FrAccord Healthcare launches Herceptin biosimilar in the UK
DoOncimmune partners with Genentech to profile samples from rheumatology trials
DoVerona Pharma launches late-stage COPD trial programme
DoFDA and EMA accept regulatory submissions for UCB's bimekizumab
DoNHS COVID-19 app launches in England and Wales
MiDigital tech has health benefits for dementia patients, project finds
MiOwlstone Medical's breath biopsy test improves detection of liver disease
MiVertex, CRISPR Therapeutics' sickle cell gene therapy wins PRIME designation
MiSanofi, GSK ink deal with EU for 300 million COVID-19 vaccine doses
DiBristol Myers Squibb's Opdivo shows benefit in oesophageal cancers
DiRoche acquires Irish biotech firm Inflazome
DiGSK's Zejula and AstraZeneca's Lynparza leap toward broader EU approval
DiUK's chief medical officers upgrade coronavirus alert level
MoKeytruda/Lenvima combo shows promise in hard-to-treat cancers
MoUniversity of Edinburgh spinout Cellinta will develop gene therapies for cancer
MoLynparza scores long-term benefit data in BRCA-mutated ovarian cancer
MoCHMP backs seven new meds in September meeting
18.09.BMS' Opdivo wins new NICE lung cancer backing
18.09.Bayer's Vitrakvi shows long-term efficacy in TRK fusion-positive cancers
18.09.Access to coronavirus tests should be 'top priority', says NHS Confederation director
18.09.NICE u-turn sees Akcea's Waylivra win NHS funding
17.09.IVD industry must be supported in COVID-19 recovery strategy, says BIVDA